

Holly Cuneo
VP, Finance Operations
Holly was appointed Vice President of Finance Operations in December 2024.
In her role at Cytokinetics, Holly serves as a strategic business partner to leaders and is responsible for developing and implementing enhanced finance analytics, decision support, policies and processes.
Holly joined Cytokinetics from Vir Biotechnology where she was the Vice President and Head of FP&A. She began her career in financial consulting before transitioning to Stryker Corporation where she held progressive finance leadership positions within the company’s Endoscopy division. She has also led finance teams at Leiter’s, Gilead Sciences, and Sangamo Therapeutics.
Holly received a Bachelor of Science in Management Science from University of California, San Diego, and an MBA from the University of California, Berkeley Haas School of Business.
Outside of work, Holly enjoys spending time with her husband and two sons, exploring the Bay Area and California’s Central Coast, and cheering on the San Francisco Giants.